Purchase Order 75N91020P00878

<p>The National Cancer Institute awarded a purchase order to EMD Millipore Corp for $13,664.26 in lab and glassware supplies on January 13, 2021, with completion on January 15, 2021. No set-aside applied. Place of performance is Burlington, MA. The order is a firm fixed price purchase order for laboratory consumables and supplies.</p>

<p>The National Cancer Institute awarded a purchase order to EMD Millipore Corp for $8,785.61 on February 24, 2016, with completion scheduled for February 28, 2017. No set-aside was used. Place of performance is Bethesda, Maryland. The order covers laboratory products and supplies on a firm fixed price basis. EMD Millipore Corp, doing business as Milliporesigma, is a foreign-owned manufacturer of laboratory equipment and consumables headquartered in Burlington, Massachusetts.</p>

This $19,519.98 firm fixed-price purchase order was awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. government, to EMD Millipore Corp, a foreign-owned manufacturer of laboratory equipment and consumables doing business as Milliporesigma. The contract is for the provision of laboratory equipment with a period of performance through July 5, 2025. This award appears to be part of a larger $100 million Blanket Purchase Agreement the company holds with the National...

<p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $24,732.00 on July 17, 2020, for scientific equipment. Performance occurs in Lawrence, Massachusetts. The order uses firm fixed price and carries no small business set-aside. Ultimate completion is August 15, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Eppendorf North America, Inc. for $12,841.60 on September 22, 2020, with completion on December 22, 2020. The order covers laboratory equipment on a firm fixed-price basis. Place of performance is Bethesda, Maryland.</p>

EMD Millipore Corp, a subsidiary of Merck KGaA and provider of laboratory equipment and supplies, received a Blanket Purchase Agreement (BPA) call award from the National Cancer Institute valued at $5,242.71. The contract, executed May 27, 2014 with an ultimate completion date of May 30, 2014, utilized firm fixed pricing with no set-aside designation. Work will be performed at the contractor's facility in Billerica, Massachusetts. This award represents a task order against an existing BPA...

The National Cancer Institute (NCI) awarded a maintenance agreement valued at $10,936.47 to EMD Millipore Corp, a subsidiary of Merck KGaA and provider of laboratory equipment and supplies operating under the trade name Milliporesigma. This contract, issued on March 15, 2018, with a completion date of March 31, 2019, was executed as a Blanket Purchase Agreement (BPA) call under firm fixed-price terms. The place of performance is located in Billerica, Massachusetts, the company's headquarters...

<p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $12,180.00 on September 14, 2020, for scientific equipment on a firm fixed price basis. Performance will occur in Lawrence, Massachusetts, with an ultimate completion date of November 11, 2020. No small business set-aside was applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>

EMD Millipore Corp (doing business as Milliporesigma) received a $15,534 firm fixed-price Blanket Purchase Agreement (BPA) call award from the National Cancer Institute (NCI) on June 17, 2016, with a completion date of July 16, 2016. The contract was performed in Bethesda, Maryland and did not utilize a set-aside designation. As a subsidiary of Merck KGaA, EMD Millipore Corp is a manufacturer of laboratory products and services specializing in equipment, consumables, and technical support for...